A Real Time chemotherapy guidance tool

Rna Diagnostics is dedicated to improving cancer chemotherapy management.
The RNA Disruption Assay™ (RDA™) will provide physicians with an evaluation
of how patients are responding to chemotherapy. In real time.
If chemotherapy is working, the physician and patient can continue with confidence.
If chemotherapy is not working well enough, physicians may consider alternate therapies.
For patients, this means avoiding harmful side effects and an opportunity to improve outcomes.
This is personalized medicine.

Providing critical information to physicians
Dedicated to improving the lives of cancer patients
An international prospective clinical trial to validate the RDA™ as a tool for management of primary breast cancer treatment.

The Chemo Response Company